Month: April 2022

Addex to Present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference

Written by Customer Service on April 25, 2022. Posted in Public Companies.

Geneva, Switzerland, April 25, 2022 – Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference taking place April 27 – 28, 2022. In his presentation, scheduled for 08:30 PDT / 11:30 EDT / 16:30 BST / 17:30 CEST on April 27, 2022, Mr Dyer will provide a corporate update and discuss recent developments at Addex. A video of each presentation will be available for viewing on-demand by registered participants. Mr Dyer will be available for virtual one-on-one meetings throughout both conferences. For more information or to schedule a one-on-one meeting with management, please contact your conference...

ObsEva Announces Confirmation of Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids

Written by Customer Service on April 25, 2022. Posted in Public Companies.

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss ExchangeGENEVA, Switzerland – April 25, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has confirmed its previously adopted positive opinion, recommending approval of linzagolix for the treatment of uterine fibroids (UF). The positive CHMP opinion, which was initially adopted on December 16, 2021, was confirmed at the April 2022 CHMP meeting following further review of the linzagolix marketing authorization application. The European Commission (EC) will now review the CHMP recommendation. If approved by the EC, linzagolix will be the only approved oral GnRH antagonist...

Press release Biocartis Group NV: Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

PRESS RELEASE: 25 April 2022, 07:00 CEST Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Mechelen, Belgium, 25 April 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that three Idylla™ study posters, of which two on the SeptiCyte® RAPID (developed in collaboration with Immunexpress) and one on the Idylla™ SARS-CoV-2 Test (CE-IVD) and Idylla™ SARS-CoV-2/Flu/RSV Panel (CE-IVD), were presented at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) between 23 – 26 April in Lisbon, Portugal. Herman Verrelst, Chief Executive Officer of Biocartis, commented: “We are pleased to see three study presentations on Idylla™...

Philips delivers Q1 sales of EUR 3.9 billion, with good demand driving 5% comparable order intake growth

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

April 25, 2022 First-quarter highlightsGroup sales amounted to EUR 3.9 billion, with a 4% comparable sales decline on the back of 9% comparable sales growth in Q1 2021 Comparable order intake increased 5%, driven by the Diagnosis & Treatment businesses and Hospital Patient Monitoring Income from continuing operations amounted to a loss of EUR 152 million, compared to a loss of EUR 34 million in Q1 2021 Adjusted EBITA of EUR 243 million, or 6.2% of sales, compared to 9.5% of sales in Q1 2021 Operating cash flow was an outflow of EUR 227 million, compared to an inflow of EUR 321 million in Q1 2021 Philips provides update on Philips Respironics field action related to specific CPAP, BiPAP and mechanical ventilatorsFrans van Houten, CEO of Royal Philips:“Our customers confirm the relevance of our strategy and portfolio, as evidenced...

Interactive Kiosk Market to Reach USD 33.99 Billion by 2027 | Kiosk Industry Exhibiting CAGR of 9.8% During 2020-2027

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

Companies covered in the Interactive Kiosk Market ZIVELO (United States), Meridian Kiosks (United States), KIOSK Information Systems (United States), Olea Kiosks Inc. (United States), SITA (Switzerland), NCR Corporation (United States), Diebold Nixdorf, Inc. (United States), Advantech Co., Ltd. (Taiwan), Embross (Canada), Glory Global Solutions (International) Limited (United Kingdom), iQmetrix (Canada), REDYREF (United States), DynaTouch (United States), Peerless-AV (Germany), CSA Service Solutions (United States), H32 Design and Development, LLC (United States) Pune, India, April 25, 2022 (GLOBE NEWSWIRE) — The global interactive kiosk market size is expected to showcase exponential growth by reaching USD 33.99 billion by 2027 while exhibiting a CAGR of 9.8% between 2020 and 2027. This growth is attributable to the rising healthcare...

Modular Construction Market Worth USD 114.78 Billion by 2028 | Modular Construction Industry Exhibiting CAGR of 6.1% During 2021-2028

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

Companies covered in the modular construction market are Guerdon Modular Buildings, Laing O’Rourke, ATCO, Red Sea International Company, Bouygues Construction, VINCI Construction Grands Projets, Skanska AB, Algeco, KLEUSBERG GmbH & Co. KG, Katerra, Lendlease Corporation. Pune, india, April 25, 2022 (GLOBE NEWSWIRE) — The global Modular Construction Market size is expected to gain momentum by reaching USD 114.78 billion by 2028 while exhibiting a CAGR of 6.1% between 2021 and 2028. This information is published by Fortune Business Insights in its latest report, titled, “Modular Construction Market, 2021-2028.” The report further observes that the market stood at USD 72.11 billion in 2020. Factors such as adoption of advanced lean manufacturing techniques and the growing infrastructure investment are expected to boost...

American Premium Water Corp. to Acquire CloudXchange DataCentre Inc. to Focus on Crypto-Mining Related Businesses With Earnings Guarantee of US$1.5 Million for the First 12 Months

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

American Premium Water Corp. to Change Focus to Crypto-mining Related Businesses, Will Change Name of Company to Reflect New Focus PLAYA VISTA, CA, April 24, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – American Premium Water Corporation (OTC:HIPH) (“APW” or the “Company”) is pleased to announce that its Board of Directors has approved the acquisition of 100% ownership of CloudXchange DataCentre Inc. (“CloudX”), an entity that engages in crypto-mining related business through its wholly owned subsidiary CloudXchange DataCentre Pte Ltd (“CloudX SG”), to diversify the Company’s earnings. The purchase price of the transaction will be at a consideration of US$45.6 million, which reflects a projected price-to-earnings ratio of 30. To fund the acquisition, the Company will issue restricted common shares of equivalent...

Applied Molecular Transport to Report Top-line Phase 2 Results from FILLMORE Trial of Oral AMT-101 in Patients with Chronic Pouchitis

Written by Customer Service on April 24, 2022. Posted in Public Companies.

– Live Conference Call and Webcast on Monday, April 25, 2022, at 8:30 a.m. ET (5:30 a.m. PT) SOUTH SAN FRANCISCO, Calif., April 24, 2022 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT) today announced that the company plans to report top-line data results from its Phase 2 FILLMORE monotherapy trial for AMT-101 (GI- selective, oral fusion of IL-10) in patients with chronic pouchitis in a premarket press release and webcasted conference call on Monday, April 25, 2022, at 8:30 a.m. ET (5:30 a.m. PT). Conference Call & Webcast InformationTo participate in the conference call, please dial (844) 422-9742 (Domestic) or (706) 758-6032 (International) and refer to conference ID 5649019. The live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. About...

Vislink Will Demonstrate New AeroLink Air-to-Ground System for Live News and Sports Applications at NAB 2022

Written by Customer Service on April 24, 2022. Posted in Public Companies.

World’s First Bi-Directional COFDM/5G/Mesh System Provides Breaking News and Sports Aerial Coverage with Seamless Distribution to all Platforms Mt. Olive, NJ, April 24, 2022 (GLOBE NEWSWIRE) — Vislink (Nasdaq: VISL), a global technology leader in the capture, delivery and management of high quality, live video and associated data in the media & entertainment, law enforcement and defense markets, will showcase how the new AeroLink downlink solution supports live news and sports applications at NAB 2022 in Las Vegas, NV, April 23-27. Vislink and Mobile Viewpoint team members will be onsite in booth #C7508. AeroLink was introduced at the recent HAI HELI-EXPO 2022 event in Dallas, Texas, where it was enthusiastically received by members of the public safety community that employ helicopters in their law enforcement and newsgathering...

Molecular Partners Announces Presentation of the EMPATHY Study of Ensovibep for the Treatment of COVID-19 at ECCMID 2022

Written by Customer Service on April 23, 2022. Posted in Public Companies.

Month: April 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals